Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-FR Version v1-EN
Language French English
Date Updated 2020-01-14 2019-09-24
Drug Identification Number 02443716 02443716
Brand name MAR-RANITIDINE MAR-RANITIDINE
Common or Proper name RANITIDINE RANITIDINE
Company Name MARCAN PHARMACEUTICALS INC MARCAN PHARMACEUTICALS INC
Ingredients RANITIDINE RANITIDINE
Strength(s) 300MG 300MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 100 Tablet 100 Tablet
ATC code A02BA A02BA
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2019-09-16 2019-09-16
Actual start date 2019-09-16 2019-09-16
Estimated end date 2020-01-10 Unknown
Actual end date 2020-01-10
Shortage status Resolved Actual shortage
Company comments
Health Canada comments